Highlight Capital

Hongpu Technology is a high-tech enterprise that independently develops high-end instruments and provides high-tech solutions.

Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.

Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.

Jiamai specializes in the manufacture of precision pneumatic components. It mainly develops and produces precision slide cylinders, pneumatic fingers, digital pressure sensors, and other pneumatic components. Their products are widely used in LCD, OLED, smartphones, lasers, lithium batteries, and other consumer electronics equipment.

Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.

ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.

Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.

Wuxi Gongwang inductive sensor developer offering high-precision, oil and dust-resistant products for various industries, including aerospace, automotive, medical care, and more.

MCT (Milli Intelligence) is an innovative company that specializes in intelligent space-time sensing chips and solutions. It is dedicated to providing top-tier products and services to consumers in autonomous driving, intelligent robotics, IoT, shared travel, digital twins, vertical industries, and other areas.

EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.

Shifan Microelectronics offers intelligent display SOC chip design and development services. Shifan Microelectronics is primarily concerned with the research and development of display processing and device technologies.

Hydropeng Technology is a company that developes solid oxide fuel cell specializes in the engineering development of solid oxide fuel cells (SOFC) and electrolytic cells (SOEC). Hydropeng Technology applies its extensive R&D capabilities in materials, chemistry, mechanics, and other fields to create efficient hydrogen energy systems that fulfill the green energy demands of global ESG development.

Aoli Biotechnology is a biopharmaceutical oral delivery technology provider. Aoli Biotechnology focuses on research into macromolecule oral delivery technology and has developed a number of world-leading excipient technology patents, including soteria and phloral technology.

Tachem is a biotechnology company that specializes in the research, development, production, and distribution of products from the protected amino acid series.

Hongce Precision is a provider of wafer-level chip inspection solutions that specializes in developing domestic chip detection technology.

Stand Group provides diversified testing and R&D services to national and global markets in health, economic, and social development fields.

Viva Biotech Holdings is a Shanghai-based company that specializes in structure-based drug discovery services for biotechnology and pharmaceutical clients worldwide. Founded in 2008, the company offers a comprehensive range of research and development services, including fragment-based drug discovery and advanced screening technologies such as affinity selection mass spectrometry and cryo-electron microscopy. Viva Biotech provides various products, including cell lines, crystal structures, GPCR proteins, and antibodies, alongside services in medicinal chemistry, in vitro pharmacology, and antibody discovery. The company operates as an integrated drug discovery platform, combining its expertise in early-stage drug research with contract development and manufacturing services for small molecule active pharmaceutical ingredients and intermediates. Its innovative approach and advanced technological platforms position Viva Biotech as a valuable partner in the global drug development landscape.

Acchrom, operating under Huapu Instrument (Beijing) Technology Co., Ltd., specializes in chromatographic separation products, offering comprehensive solutions that include equipment, consumables, software, and technical services. The company aims to establish itself as a leading national brand in chromatography by developing targeted marketing strategies and building a professional marketing network across key provinces. Acchrom's focus on the complete chromatography process enables clients to effectively analyze and separate mixtures, positioning the company as a significant player in the field.

Rgenta Therapeutics, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, specializing in the development of RNA-targeting medicines with a primary focus on oncology and neurological disorders. Founded in 2018, the company utilizes a proprietary platform that analyzes extensive genomic data to identify targetable RNA processing events. This platform enables the design of small-molecule compounds that modulate interactions among the spliceosome, regulatory proteins, and RNAs. By unlocking the therapeutic potential of previously undruggable targets, Rgenta aims to create oral, small-molecule therapies that address critical needs in human disease treatment, particularly in the realm of cancer.

Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics，pesticides，veterinary drugs, and new cosmetics.

Hongyixin is an automotive electronic chip developer.

Etana is focused on the production and sales of biopharmaceuticals for oncology and life-threatening diseases.

ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.

Base Therapeutics offers cell and gene editing technology designed to treat cancerous diseases. The company's technology includes a natural killer cell genetic engineering platform and other cell therapy products for treatments of lung cancer, liver cancer, glioma, and other hematological tumors

Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples in biosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad.

Etana is focused on the production and sales of biopharmaceuticals for oncology and life-threatening diseases.

Silicon Innovation is a technology company based in Chengdu, China, specializing in interconnect chip solutions for the enterprise sector. Established in December 2019, the company focuses on the development of high-end analog and digital-analog hybrid chips, which cater to various applications including clocks, interfaces, and power management. Silicon Innovation's products support critical industries such as data centers, 5G communications, artificial intelligence, autonomous driving, intelligent monitoring, new energy vehicles, and the Internet of Things. By providing advanced chip solutions, the company enables businesses to enhance their systems and products across multiple sectors.

Bibst Automotive Electronics is a provider of automotive electronic products. Bibst provides intelligent chassis core components, chassis domain controllers, and autonomous driving-related technical services.

Yaotan Pharmaceutical offers one-stop CDMO services for the research and production of raw materials and preparations CMC, covering the formulation process development, quality research, registration, and declaration of chemical raw materials and preparations, as well as for customers. They adhere to the unique concept and original aim of assisting the globe in the discovery and development of novel drugs. They are committed to establishing a service platform for small-molecule medication research and development.

MediLink Therapeutics is a biotechnology company based in Suzhou, China, specializing in the development of next-generation antibody-drug conjugates (ADCs). The company aims to address significant unmet medical needs in China by creating innovative therapeutics that target cancer while minimizing damage to healthy cells. MediLink Therapeutics is committed to enhancing patient outcomes through its research and development efforts, which include conducting multicenter clinical trials and engaging in cross-border collaborations to generate global value. By focusing on ADCs, the company strives to improve the efficacy of cancer treatments while ensuring patient safety during therapy.

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.

Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and located in Haimen, China, specializes in contract development and manufacturing services tailored for the biotechnology sector. The company focuses on developing biopharmaceutical technologies aimed at producing protein and vaccine compounds. It offers integrated control solutions that enhance production processes by optimizing protein expression and reducing production scale. This enables biopharmaceutical companies to access personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services. By providing these comprehensive services, Thousand Oaks Biopharmaceuticals aims to facilitate the creation of accessible and affordable biologics to meet global healthcare needs.

ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the γδ-T cell immunotherapy industry. Committed to bringing good news to patients with refractory and recurrent solid tumors and hematomas.

Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.

Inmagene Biopharmaceuticals Co. Ltd. is a Shanghai-based company specializing in the research and pre-clinical development of therapies for immunology-related conditions. Founded in 2019, it focuses on addressing unmet medical needs globally through a unique approach termed "Borderless Innovation." The company is developing a pipeline of drug candidates, including IMG-020, a protein drug designed to target IL-17A, utilizing advanced technologies that enhance potency and extend the drug's half-life. Inmagene aims to create a new generation of therapeutics characterized by improved pharmacokinetics, pharmacodynamics, and safety profiles, which may lead to better efficacy and dosing convenience. With additional offices in Hangzhou and Beijing, Inmagene is committed to leveraging innovative resources and processes to facilitate drug development across borders, thereby enhancing the potential for positive patient outcomes worldwide.

Chongxing Chongwu is a supplier of pet supplies.

Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.

Zonsen Peplib Biotech builds a peptide compound library and provides peptide drug discovery and development services for global pharmaceutical and biotech companies. The company's technology could compress the amino acid sequence information of about 500,000,000 peptides into 80,000 peptide compounds.

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform, providing first-in-class new molecules consistently and efficiently. Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China.

Biotheus Inc. is a biotechnology company based in Zhuhai, China, established in 2018. The company specializes in the development of monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals, with a focus on treating malignant tumors and autoimmune diseases. Biotheus is dedicated to advancing innovative biologics through the discovery and commercialization of next-generation multispecific antibodies. Its research emphasizes the mechanisms of regulatory T cells and innate immunity, aiming to create more effective immunotherapy solutions for cancer and metabolic disorders.

Novast Holdings Ltd. is a multinational pharmaceutical company with operations in China and the United States, specializing in the research, development, and manufacture of FDA-inspected generic drugs. The company focuses on creating complex formulations that incorporate challenging active pharmaceutical ingredients (APIs) and offers product development services leveraging its expertise in novel technologies and drug delivery systems. Novast has established itself as a prominent player in the pharmaceutical industry in China, possessing unique capabilities in drug development, quality systems, and infrastructure. It collaborates with pharmaceutical and biotechnology companies to bring products to regulated markets, particularly the U.S. market, where it is recognized as a pioneer among Chinese companies selling pharmaceuticals locally. Novast also operates cGMP manufacturing facilities and has a management team experienced in securing numerous generic drug patents in the U.S., alongside independent research and development of innovative drug-delivery technologies.

Imago BioSciences is a clinical-stage biotechnology company based in Redwood City, California, that specializes in developing innovative medicines for hematologic diseases. Founded in 2012, the company focuses on therapeutics that target genetic and epigenetic factors, specifically through the inhibition of lysine-specific demethylase 1 (LSD1), an enzyme crucial in blood cell production. Imago BioSciences aims to address significant medical challenges associated with conditions such as leukemia, myelodysplastic syndrome, and other bone marrow disorders. Its lead product candidate, Bomedemstat, is an orally available small molecule designed to treat certain myeloproliferative neoplasms, with the goal of altering disease progression and improving the quality and longevity of patients' lives.

Xingyun Group specializes in reconstructing the digital supply chain for consumer goods, offering comprehensive Direct-to-Consumer (DTC) services. The company utilizes whole-process SaaS tools to enhance the global commodity trade environment. Its Management Middle-end System Services Engine focuses on integrating industrial resources to reduce costs and improve efficiency through data-driven insights. Xingyun Group assists overseas consumer brands in entering the Chinese market while also facilitating the global expansion of Chinese brands. The company boasts nearly 160 warehouses located in 72 countries and one region, serving over 350,000 retailers both online and offline in China. Its platform encompasses a diverse range of products, including maternal and child supplies, beauty care, healthcare, and clothing, enabling retailers to procure goods quickly and cost-effectively.

Gaugene specializes in providing advanced hematology testing instruments, reagents, and services tailored for in vitro diagnostic (IVD) users. As a high-tech enterprise, it is backed by experienced professionals from prominent domestic IVD companies who possess expertise in leading-edge technologies. The company’s instruments are unique in China, featuring high-power flow lasers and high-sensitivity multi-color fluorescence detection systems. These innovations enable a wide range of applications, including hematology diagnosis, clinical diagnosis, and life science research. Gaugene's solutions support clinical diagnostics and flow cytometry technology, facilitating single-cell research, protein screening, and the discovery of new clinical indicators.

Soocas (Shenzhen) Technology Co., Ltd., established in 2015, specializes in personal digital health care products, focusing on innovative solutions for oral hygiene and personal care. The company is well-known for its sonic electronic toothbrushes, particularly the flagship model X3, and also offers products like blow dryers and shaving razors, all designed to integrate seamlessly within the Xiaomi ecosystem. Soocas emphasizes research and development to create high-performance, intelligent products tailored to consumer needs. The team comprises experienced professionals from leading hardware companies, bringing extensive knowledge in product design and user experience. With a commitment to innovation and quality, Soocas aims to enhance personal health care through its advanced electronic products.

Hanyu Medical is a pioneering company in the development, production, and sale of transcatheter mitral valve repair devices, focusing on innovative solutions for heart valve diseases. Its primary product, Valve Clamp, is an interventional device designed for minimally invasive treatment of mitral valve regurgitation. This device facilitates the closure of heart valves during operations, allowing surgeons to perform heart surgeries with reduced invasiveness. Hanyu Medical's commitment to advancing medical technology positions it as a significant player in the cardiovascular device market.

Novast Holdings Ltd. is a multinational pharmaceutical company with operations in China and the United States, specializing in the research, development, and manufacture of FDA-inspected generic drugs. The company focuses on creating complex formulations that incorporate challenging active pharmaceutical ingredients (APIs) and offers product development services leveraging its expertise in novel technologies and drug delivery systems. Novast has established itself as a prominent player in the pharmaceutical industry in China, possessing unique capabilities in drug development, quality systems, and infrastructure. It collaborates with pharmaceutical and biotechnology companies to bring products to regulated markets, particularly the U.S. market, where it is recognized as a pioneer among Chinese companies selling pharmaceuticals locally. Novast also operates cGMP manufacturing facilities and has a management team experienced in securing numerous generic drug patents in the U.S., alongside independent research and development of innovative drug-delivery technologies.

ChosenMed is a healthcare company specializing in oncology precision medicine. It is dedicated to early tumor screening and companion diagnosis, aiming to improve patient outcomes in cancer care. The company develops products that address the early screening, prevention, and diagnosis of tumors. Additionally, ChosenMed provides guidance for targeted medication related to solid tumors and predicts the efficacy of tumor immunotherapy. By offering a comprehensive range of precision medical solutions and immunotherapy options, ChosenMed strives to enhance treatment effectiveness and support personalized patient care in oncology.

GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

4iNLOOK was founded in 2008 and now has more than 300 specialty color contact lens stores nationwide, mainly in shopping centers in first-and second-tier cities. It offers more than 200 color contact lens options with different designs for women aged 18-30. Meanwhile, 4iNLOOK is also opening up online channels, with its Tmall store and national chain stores offering a new retail shopping experience that allows consumers to place orders online, take orders offline, make appointments online, and experience the products offline.

Xinjunte has focused on the research and development of intelligent medical devices for bone surgery, and is committed to providing more efficient and safe medical devices.

EnnovaBio is a Chinese pharmaceutical company that specializes in the development of targeted therapeutic drugs. The company focuses on creating innovative immunotherapy pharmaceuticals aimed at treating prevalent autoimmune diseases and brain glioma. By concentrating on both cancer and autoimmune conditions, EnnovaBio seeks to provide effective treatment options that enhance patient outcomes and support medical practitioners in their efforts to address complex health challenges. Through its research and development initiatives, EnnovaBio aims to advance the field of immunotherapy and contribute to improved healthcare solutions in China.

Genetron Health is a prominent oncology company based in China, specializing in precision medicine and cancer molecular profiling. The firm focuses on developing health management products that encompass all aspects of cancer clinical treatment, including risk assessment, early screening, molecular pathology diagnosis, medication guidance, and prognosis monitoring. By leveraging advanced technologies in molecular biology and data science, Genetron Health effectively applies genomic data to support medical professionals and researchers. The company offers reliable molecular clinical services and professional cancer genetic risk assessments to patients, including those at high risk and healthy individuals. Over three years, Genetron Health has established global genomics sequencing and bioinformatics platforms, alongside R&D centers in North Carolina and Beijing, and clinical laboratories across several Chinese cities. Looking ahead, Genetron Health plans to expand its sales network throughout China, aiming to provide comprehensive services to both Chinese and global cancer patients, supported by its expertise in cancer genomics and clinical translation.

Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.

Verseau Therapeutics, Inc. is focused on developing macrophage checkpoint modulators aimed at treating patients with cancer, as well as immune and inflammatory diseases. Founded in 2017 and based in Lexington, Massachusetts, the company is creating a new class of therapeutics that target macrophages, which are crucial cells in the immune system. By shifting these cells between immune activators and silencers, Verseau's therapies aim to enhance the body's ability to mount an effective immune response against tumors. This innovative approach seeks to improve the efficacy of existing immunotherapies, offering new hope for patients facing challenging health conditions.

Julikang is a third-party medical device disinfection service provider focused on the healthcare industry in China. The company offers disinfection services to numerous hospitals, utilizing automated cleaning devices to ensure thorough sanitation of items and areas. By interfacing with hospital information systems, Julikang implements sterile item traceability management software, which enhances the management of sterile articles. This integration allows real-time access to physical parameter information of medical devices, ensuring efficient traceability and compliance with hygiene standards. Through its services, Julikang aims to deliver professional quality sterilization and disinfection solutions to healthcare enterprises.

Loving Care International Pet Hospital is a comprehensive animal medical institution that operates a chain of clinics and hospitals focused on pet healthcare services. The facility offers a range of services including beauty treatments, physical examinations, vaccinations, and clinics. In addition to standard medical care, Loving Care provides users with information on the prevention of common diseases in dogs and cats, as well as alternative pet health issues. The establishment also operates mobile animal service vehicles to deliver home-based basic medical services, ensuring that pets receive the care they need in a convenient manner. Through its commitment to improving the diagnosis and treatment of pet diseases, including serious conditions such as tumors, Loving Care aims to enhance the overall well-being of animals and support pet owners in maintaining their pets' health.

Angstrom STEM is a brand of Anglia Education Group, integrating the resources and achievements of science and technology education of Shanghai Jiaotong University, and introducing the technology experience model of the United States and Canada, innovatively opening up STEM entertainment and education, integrating scientific experiments, model construction, mechanical energy, robot construction With programming, 3D printing, mathematics, etc., and focusing on the application and innovation of the latest science and technology, we have established a complete scientific STEM curriculum system to promote the quality education of domestic children and build a leading high-end STEM education brand in China.

Bitwise is a cryptocurrency-focused asset manager that provides investment solutions for individuals, investment managers, and institutions. The company offers a diverse range of 32 investment products, including yield and alpha strategies, multi-strategy solutions, separately managed accounts, onchain staking, and index funds. It aims to facilitate access to the cryptocurrency market by offering secure, liquid, and low-cost investment options. By employing modern security measures, Bitwise ensures the protection of clients' assets while delivering rules-based exposure to the crypto-asset space, thus helping clients achieve their financial objectives.

NewDoon is a research, development, and manufacturing company of life science products and solutions. It is a company that develops neuroscience products and solutions. They have developed wireless optogenetics systems, fiber photometry systems, and miniaturized fluorescence microscopy.

Cullgen Inc. is a biopharmaceutical company based in San Diego, California, founded in 2018. The company specializes in developing first-in-class new chemical entities (NCEs) aimed at treating diseases that currently lack effective therapeutic options. Utilizing its proprietary uSMITE™ platform, Cullgen focuses on small molecule therapeutics that employ targeted protein degradation technology. This innovative approach selectively degrades disease-causing proteins, offering potential treatments for cancer, inflammatory, and autoimmune diseases, including targets that have been previously deemed undruggable. By advancing drug discovery in these challenging areas, Cullgen aims to provide novel therapeutic approaches to improve patient outcomes.

Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products, pesticides, etc., and has contributed to the promotion and development of green chemistry.

Imago BioSciences is a clinical-stage biotechnology company based in Redwood City, California, that specializes in developing innovative medicines for hematologic diseases. Founded in 2012, the company focuses on therapeutics that target genetic and epigenetic factors, specifically through the inhibition of lysine-specific demethylase 1 (LSD1), an enzyme crucial in blood cell production. Imago BioSciences aims to address significant medical challenges associated with conditions such as leukemia, myelodysplastic syndrome, and other bone marrow disorders. Its lead product candidate, Bomedemstat, is an orally available small molecule designed to treat certain myeloproliferative neoplasms, with the goal of altering disease progression and improving the quality and longevity of patients' lives.

Boholo, founded in 2011 and based in Shanghai, China, offers a digital medical management solution that integrates various advanced technologies. Its platform includes services such as clinical case management, three-dimensional surgical modeling and planning, and a multimedia case database. By utilizing artificial intelligence and machine vision, Boholo's medical imaging tools generate precise 3D anatomical models that assist medical professionals in planning surgical procedures, thereby increasing the likelihood of successful outcomes. The company also provides a comprehensive service platform that facilitates communication among specialists worldwide, enhancing their ability to deliver quality care.

BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.

GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

Biotheus Inc. is a biotechnology company based in Zhuhai, China, established in 2018. The company specializes in the development of monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals, with a focus on treating malignant tumors and autoimmune diseases. Biotheus is dedicated to advancing innovative biologics through the discovery and commercialization of next-generation multispecific antibodies. Its research emphasizes the mechanisms of regulatory T cells and innate immunity, aiming to create more effective immunotherapy solutions for cancer and metabolic disorders.

MALO CLINIC was established in 1995 by Dr. Paulo Malo. Today is world’s leader in Implantology and Dental Cosmetic as well as an Educational Centre on Oral Rehabilitation that trains over 3,500 professionals coming from all over the world per year. Besides Dentistry MALO CLINIC expanded to other health specialties, projecting an innovative concept of Medical Spa through a strong bet in wellbeing which resulted in the foundation of a Health Management business group spread worldwide known as MALO CLINIC Health & Wellness.

Predicine Huidu Medical Technology Co., Ltd. is located in Fengxian, China, and specializes in the research and development of innovative technologies in the healthcare sector. The company focuses on gene detection methods and bioinformatics algorithms specifically designed for cancer diagnosis and monitoring. By creating a clinical application platform, Predicine Huidu Medical Technology connects patients with healthcare companies, facilitating advancements in tumor diagnosis and treatment. Through its technological offerings, the company aims to enhance the accuracy and effectiveness of cancer care.

Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its services encompass a range of clinical inspection instruments, including chemiluminescence and biochemical reagents, as well as technical support, management, and certification. Additionally, Chemclin operates independent medical laboratories and is focused on introducing innovative diagnostic products and services to the Chinese market.

Gaugene specializes in providing advanced hematology testing instruments, reagents, and services tailored for in vitro diagnostic (IVD) users. As a high-tech enterprise, it is backed by experienced professionals from prominent domestic IVD companies who possess expertise in leading-edge technologies. The company’s instruments are unique in China, featuring high-power flow lasers and high-sensitivity multi-color fluorescence detection systems. These innovations enable a wide range of applications, including hematology diagnosis, clinical diagnosis, and life science research. Gaugene's solutions support clinical diagnostics and flow cytometry technology, facilitating single-cell research, protein screening, and the discovery of new clinical indicators.

Chowsing Live is an online retailer based in Shanghai, China, specializing in pet products and accessories. The company offers a range of items, including pet jumbo wipes, cat collars with bells, and flushable cat litters. Chowsing Live focuses on promoting design and creativity in its product development, aiming to address the genuine needs of pets and their owners. By providing innovative solutions, the company strives to foster a natural and harmonious lifestyle for both pets and pet-raising families.

MoonBiotech is a biotechnology company focused on the commercialization of microbial resources.

ChosenMed is a healthcare company specializing in oncology precision medicine. It is dedicated to early tumor screening and companion diagnosis, aiming to improve patient outcomes in cancer care. The company develops products that address the early screening, prevention, and diagnosis of tumors. Additionally, ChosenMed provides guidance for targeted medication related to solid tumors and predicts the efficacy of tumor immunotherapy. By offering a comprehensive range of precision medical solutions and immunotherapy options, ChosenMed strives to enhance treatment effectiveness and support personalized patient care in oncology.

GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

Kunya Medical is a provider of medical equipment management services focused on enhancing the maintenance and operational efficiency of hospital equipment. The company offers comprehensive services, including the maintenance and hosting of hospital imaging and radiation equipment, as well as installation, debugging, and repair of large and medium-sized medical devices. Kunya Medical also supplies spare parts and management software, facilitating improved oversight and longevity of clinical medical equipment for hospitals. By outsourcing these critical functions, Kunya Medical aims to help healthcare facilities optimize their equipment management and extend the lifecycle of their medical assets.

Chongxing Chongwu is a supplier of pet supplies.

Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.

Sansure Biotech Inc. is a biotechnology company based in Changsha, Hunan Province, specializing in molecular diagnostics and genetic testing. Established in 2008, the company develops and sells a range of products, including nucleic acid extraction kits and real-time PCR diagnostic and research kits, as well as fluorescence systems. Its offerings include diagnostic kits for various diseases such as COVID-19, viral hepatitis, AIDS, cancer-related biomarkers, and respiratory tract infections, among others. Sansure Biotech serves hospitals and laboratories both in China and internationally, providing essential medical devices and laboratory equipment designed for accurate diagnoses and research in the field of molecular biology.

Loving Care International Pet Hospital is a comprehensive animal medical institution that operates a chain of clinics and hospitals focused on pet healthcare services. The facility offers a range of services including beauty treatments, physical examinations, vaccinations, and clinics. In addition to standard medical care, Loving Care provides users with information on the prevention of common diseases in dogs and cats, as well as alternative pet health issues. The establishment also operates mobile animal service vehicles to deliver home-based basic medical services, ensuring that pets receive the care they need in a convenient manner. Through its commitment to improving the diagnosis and treatment of pet diseases, including serious conditions such as tumors, Loving Care aims to enhance the overall well-being of animals and support pet owners in maintaining their pets' health.

EnnovaBio is a Chinese pharmaceutical company that specializes in the development of targeted therapeutic drugs. The company focuses on creating innovative immunotherapy pharmaceuticals aimed at treating prevalent autoimmune diseases and brain glioma. By concentrating on both cancer and autoimmune conditions, EnnovaBio seeks to provide effective treatment options that enhance patient outcomes and support medical practitioners in their efforts to address complex health challenges. Through its research and development initiatives, EnnovaBio aims to advance the field of immunotherapy and contribute to improved healthcare solutions in China.

WinnTi Medical creates medical devices through continuous product innovations and manufacturing improvements, meeting surgeons' increasing demands, and improving patients' wellness.

General Healthy specializes in pharmaceutical logistics automation and mobile medical solutions. Based in Shanghai, the company offers products and services designed for the intelligent management of medicines, catering to both medical services and the pharmaceutical circulation industries. Through its innovative approach, General Healthy aims to enhance the efficiency and effectiveness of medicine management, addressing the needs of healthcare providers and pharmaceutical distributors.

Xiao Qu Hao Hushi provides online medical consultancy services through an application.

Rundong Pharmaceutical R&D is a contract research organization (CRO) that focuses on clinical research outsourcing for pharmaceutical and biotechnology companies. It offers a comprehensive range of services, including clinical operations, medical data management, biostatistics, and medical project management. As a key player in the industry, Rundong is the main initiator and promoter of the China CRO Alliance, highlighting its leadership role in the field. The company has also achieved the distinction of being the first CRO in China to receive ISO 9001:2008 quality management system certification, demonstrating its commitment to high-quality standards in clinical research. Through its professional services, Rundong aims to support various companies in the pharmaceutical and biotech sectors in advancing their medical research initiatives.

Xanthus Media is an animation production company. They involve in presenting audio-visual feasts and conveying emotional value. Screenwriting, designing, special effects, strategic consulting, management, and marketing are the business line of this company.